packageVenetoclax

venetoclax

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Venetoclax is an anticancer medicine used to treat blood cancers such as chronic lymphocytic leukemia, acute myeloid leukemia, and certain B-cell lymphomas. It is an approved medicine and is authorised in the European Union for chronic lymphocytic leukemia.

Summary written by glm-5.3-flash from Wikidata Q23671272 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:venetoclax
ATC codes:L01XX52
DrugBank:DB11581
PubChem CID:49846579
ChEBI:133021
Wikidata:Q23671272
formula:C45H50ClN7O7S
molar mass:868.447 g/mol (PubChem CID 49846579)
logP:8.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown